首页 > 最新文献

Pediatric Annals最新文献

英文 中文
Loss to Follow-Up: Patients with Type 1 Diabetes During the SARS-CoV-2 Pandemic. 失去随访:SARS-CoV-2大流行期间的1型糖尿病患者。
IF 1.1 4区 医学 Q3 PEDIATRICS Pub Date : 2024-07-01 DOI: 10.3928/19382359-20240502-04
Erin Skelly, Delaney Tognolini

The SARS-CoV-2 (severe acute respiratory syndrome related coronavirus 2) pandemic revealed many flaws in our health care system. This review aims to explore the significance of loss to follow-up on patients with type 1 diabetes during the pandemic, the morbidity and mortality associated, and strategies to prevent loss to follow-up or to re-engage patients in longitudinal care. [Pediatr Ann. 2024;53(7):e254-e257.].

SARS-CoV-2(严重急性呼吸系统综合征相关冠状病毒 2)大流行暴露了我们医疗保健系统的许多缺陷。本综述旨在探讨大流行期间 1 型糖尿病患者失去随访的意义、相关的发病率和死亡率,以及防止失去随访或让患者重新参与纵向护理的策略。[2024;53(7):e254-e257.].
{"title":"Loss to Follow-Up: Patients with Type 1 Diabetes During the SARS-CoV-2 Pandemic.","authors":"Erin Skelly, Delaney Tognolini","doi":"10.3928/19382359-20240502-04","DOIUrl":"https://doi.org/10.3928/19382359-20240502-04","url":null,"abstract":"<p><p>The SARS-CoV-2 (severe acute respiratory syndrome related coronavirus 2) pandemic revealed many flaws in our health care system. This review aims to explore the significance of loss to follow-up on patients with type 1 diabetes during the pandemic, the morbidity and mortality associated, and strategies to prevent loss to follow-up or to re-engage patients in longitudinal care. <b>[<i>Pediatr Ann</i>. 2024;53(7):e254-e257.]</b>.</p>","PeriodicalId":54633,"journal":{"name":"Pediatric Annals","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141477972","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Review of Urinary Tract Infections and Pyelonephritis. 尿路感染和肾盂肾炎回顾。
IF 1.1 4区 医学 Q3 Medicine Pub Date : 2024-06-01 DOI: 10.3928/19382359-20240407-05
Kimberly Pianucci, Frank Cipriano, Erica Chung

Urinary tract infections (UTIs) are serious bacterial infections affecting children of all ages. An understanding of the methods of urine collection is important to prevent the contamination of urine specimens and to interpret results. The diagnosis of a UTI requires appropriate interpretation of both urinalysis and urine culture results because testing must indicate evidence of inflammation and the presence of bacteria. Rapid treatment of UTIs is imperative to prevent acute decompensation and systemic illness. Empiric antibiotics should be narrowed as soon as possible to tailor antibiotic treatment and limit antibiotic overuse. Imaging with a renal ultrasound scan is recommended for all infants with first febrile UTIs rather than a voiding cystourethrogram. An additional goal of UTI treatment is to prevent renal scarring, which can lead to lifelong health consequences. Children with anatomic abnormalities of the urinary tract and those who have recurrent UTIs are at increased risk of renal scarring. [Pediatr Ann. 2024;53(6):e217-e222.].

尿路感染(UTI)是一种严重的细菌感染,影响各个年龄段的儿童。了解尿液采集方法对于防止尿液标本污染和解释结果非常重要。尿道炎的诊断需要对尿液分析和尿液培养结果做出适当的解释,因为检测必须显示炎症和细菌存在的证据。快速治疗尿毒症是防止急性衰竭和全身性疾病的当务之急。应尽快缩小经验性抗生素的使用范围,以便有针对性地进行抗生素治疗,并限制抗生素的过度使用。建议对所有首次发热性尿毒症的婴儿进行肾脏超声波扫描,而不是进行排尿膀胱尿道造影。尿毒症治疗的另一个目标是防止肾脏瘢痕形成,因为瘢痕形成可能导致终生健康问题。泌尿道解剖异常的儿童和反复患尿毒症的儿童患肾脏瘢痕的风险更高。[2024;53(6):e217-e222.].
{"title":"Review of Urinary Tract Infections and Pyelonephritis.","authors":"Kimberly Pianucci, Frank Cipriano, Erica Chung","doi":"10.3928/19382359-20240407-05","DOIUrl":"https://doi.org/10.3928/19382359-20240407-05","url":null,"abstract":"<p><p>Urinary tract infections (UTIs) are serious bacterial infections affecting children of all ages. An understanding of the methods of urine collection is important to prevent the contamination of urine specimens and to interpret results. The diagnosis of a UTI requires appropriate interpretation of both urinalysis and urine culture results because testing must indicate evidence of inflammation and the presence of bacteria. Rapid treatment of UTIs is imperative to prevent acute decompensation and systemic illness. Empiric antibiotics should be narrowed as soon as possible to tailor antibiotic treatment and limit antibiotic overuse. Imaging with a renal ultrasound scan is recommended for all infants with first febrile UTIs rather than a voiding cystourethrogram. An additional goal of UTI treatment is to prevent renal scarring, which can lead to lifelong health consequences. Children with anatomic abnormalities of the urinary tract and those who have recurrent UTIs are at increased risk of renal scarring. <b>[<i>Pediatr Ann</i>. 2024;53(6):e217-e222.]</b>.</p>","PeriodicalId":54633,"journal":{"name":"Pediatric Annals","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141293968","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Safely Doing Less for Febrile Infants: Reviewing Management in the Setting of the 2021 American Academy of Pediatrics Clinical Practice Guideline. 安全地减少对发热婴儿的治疗:根据《2021 年美国儿科学会临床实践指南》审查管理。
IF 1.1 4区 医学 Q3 Medicine Pub Date : 2024-06-01 DOI: 10.3928/19382359-20240407-01
Abigail R Adler, Whitney L Browning

For more than 4 decades, pediatricians have sought the best practices for effectively managing well-appearing young febrile infants. In 2021, the American Academy of Pediatrics released a clinical practice guideline for the management of well-appearing febrile infants aged 8 to 60 days. The guideline incorporates advancements in testing, such as biomarkers and diagnostic testing in the setting of changing epidemiology, to help risk stratify infants in the newly formed group age 22 to 28 days as well as the group age 29 to 60 days. The new guideline uses inflammatory markers (procalcitonin, C-reactive protein, absolute neutrophil count, and a temperature >38.4°C) to identify infants at low risk for invasive bacterial infection who can potentially avoid the invasive procedures of lumbar puncture, hospitalization, and broad-spectrum antimicrobials. Because of continued ambiguity, incorporating shared decision-making with families in the care of these infants will be important, as will ongoing clinical research to better inform future practice. [Pediatr Ann. 2024;53(6):e202-e207.].

40 多年来,儿科医生一直在寻求有效管理面色红润的发热婴儿的最佳方法。2021 年,美国儿科学会发布了一份临床实践指南,用于管理 8 至 60 天内表现良好的发热婴儿。该指南在不断变化的流行病学背景下纳入了生物标志物和诊断检测等先进的检测手段,以帮助对新形成的 22 至 28 天组别以及 29 至 60 天组别中的婴儿进行风险分层。新指南使用炎症标志物(降钙素原、C 反应蛋白、绝对中性粒细胞计数和体温 >38.4°C)来识别侵入性细菌感染的低风险婴儿,这些婴儿有可能避免腰椎穿刺、住院治疗和广谱抗菌药物等侵入性程序。由于仍然存在不明确之处,因此在护理这些婴儿时与家属共同决策将非常重要,而持续的临床研究也将为未来的实践提供更好的信息。[2024; 53(6):e202-e207.].
{"title":"Safely Doing Less for Febrile Infants: Reviewing Management in the Setting of the 2021 American Academy of Pediatrics Clinical Practice Guideline.","authors":"Abigail R Adler, Whitney L Browning","doi":"10.3928/19382359-20240407-01","DOIUrl":"https://doi.org/10.3928/19382359-20240407-01","url":null,"abstract":"<p><p>For more than 4 decades, pediatricians have sought the best practices for effectively managing well-appearing young febrile infants. In 2021, the American Academy of Pediatrics released a clinical practice guideline for the management of well-appearing febrile infants aged 8 to 60 days. The guideline incorporates advancements in testing, such as biomarkers and diagnostic testing in the setting of changing epidemiology, to help risk stratify infants in the newly formed group age 22 to 28 days as well as the group age 29 to 60 days. The new guideline uses inflammatory markers (procalcitonin, C-reactive protein, absolute neutrophil count, and a temperature >38.4°C) to identify infants at low risk for invasive bacterial infection who can potentially avoid the invasive procedures of lumbar puncture, hospitalization, and broad-spectrum antimicrobials. Because of continued ambiguity, incorporating shared decision-making with families in the care of these infants will be important, as will ongoing clinical research to better inform future practice. <b>[<i>Pediatr Ann</i>. 2024;53(6):e202-e207.]</b>.</p>","PeriodicalId":54633,"journal":{"name":"Pediatric Annals","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141293970","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnosis and Treatment of Group A Streptococcal Pharyngitis in Children. 儿童 A 群链球菌咽炎的诊断和治疗。
IF 1.1 4区 医学 Q3 Medicine Pub Date : 2024-06-01 DOI: 10.3928/19382359-20240407-08
Antonietta Curatola, Lorenzo Di Sarno, Miriam Massese, Anya Caroselli, Antonio Gatto, Antonio Chiaretti

The purpose of this review is to summarize the current evidence regarding the management of streptococcal pharyngitis in children. This article aims to provide a valid support to discriminate streptococcal pharyngitis from viral cases and treat it appropriately to avoid the development of complications. Differential diagnosis based only on clinical features is not always easy. For this reason, different clinical scores were created to provide an accurate diagnosis. Microbiological tests are valuable tools as well, but their use is not recommended unanimously. Concerning treatment, all guidelines agree on the drug to be used. However, doubts remain about the optimal duration of antibiotic therapy, especially in this specific historical moment as we are experiencing a peak in streptococcal infections. [Pediatr Ann. 2024;53(6):e234-e238.].

本综述旨在总结有关儿童链球菌性咽炎治疗的现有证据。本文旨在为链球菌性咽炎与病毒性咽炎的鉴别提供有效支持,并对其进行适当治疗以避免并发症的发生。仅根据临床特征进行鉴别诊断并非易事。因此,人们制定了不同的临床评分标准,以提供准确的诊断。微生物检测也是很有价值的工具,但并未得到一致推荐。关于治疗,所有指南都同意使用药物。但是,对于抗生素治疗的最佳持续时间仍然存在疑问,尤其是在目前这个特殊的历史时期,因为我们正经历着链球菌感染的高峰期。[2024; 53(6):e234-e238.].
{"title":"Diagnosis and Treatment of Group A Streptococcal Pharyngitis in Children.","authors":"Antonietta Curatola, Lorenzo Di Sarno, Miriam Massese, Anya Caroselli, Antonio Gatto, Antonio Chiaretti","doi":"10.3928/19382359-20240407-08","DOIUrl":"https://doi.org/10.3928/19382359-20240407-08","url":null,"abstract":"<p><p>The purpose of this review is to summarize the current evidence regarding the management of streptococcal pharyngitis in children. This article aims to provide a valid support to discriminate streptococcal pharyngitis from viral cases and treat it appropriately to avoid the development of complications. Differential diagnosis based only on clinical features is not always easy. For this reason, different clinical scores were created to provide an accurate diagnosis. Microbiological tests are valuable tools as well, but their use is not recommended unanimously. Concerning treatment, all guidelines agree on the drug to be used. However, doubts remain about the optimal duration of antibiotic therapy, especially in this specific historical moment as we are experiencing a peak in streptococcal infections. <b>[<i>Pediatr Ann</i>. 2024;53(6):e234-e238.]</b>.</p>","PeriodicalId":54633,"journal":{"name":"Pediatric Annals","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141293966","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Youth Gun Violence. 青少年枪支暴力。
IF 1.1 4区 医学 Q3 Medicine Pub Date : 2024-06-01 DOI: 10.3928/19382359-20240407-04
Michael Harries

Gun violence is a rapidly growing concern for youth. As rates of death by firearm rise, so does exposure to firearm violence and high levels of accompanying morbidity. Although gun violence cannot be attributed to any one cause, it is important pediatric health care providers understand the prevalence of this issue. Additionally, the long-term health effects are profound with many victims of, and witnesses to, gun violence experiencing new symptoms of general anxiety disorder. There are numerous initiatives taking place at the individual, local, and national levels to address this public health crisis. An overview of such interventions is also presented. With better screening and treatment of upstream and downstream symptoms of youth gun violence, pediatricians can decrease the morbidity and mortality that results from firearm use. [Pediatr Ann. 2024;53(6):e197-e199.].

枪支暴力是青少年日益关注的一个问题。随着枪支致死率的上升,接触枪支暴力和伴随的高发病率也在上升。虽然枪支暴力不能归咎于任何一个原因,但儿科医疗服务提供者必须了解这一问题的普遍性。此外,枪支暴力对健康的长期影响是深远的,许多枪支暴力的受害者和目击者都会出现新的全身焦虑症症状。在个人、地方和国家层面都有许多措施来应对这一公共卫生危机。本报告对这些干预措施进行了概述。通过更好地筛查和治疗青少年枪支暴力的上游和下游症状,儿科医生可以降低因使用枪支而导致的发病率和死亡率。[2024;53(6):e197-e199.].
{"title":"Youth Gun Violence.","authors":"Michael Harries","doi":"10.3928/19382359-20240407-04","DOIUrl":"https://doi.org/10.3928/19382359-20240407-04","url":null,"abstract":"<p><p>Gun violence is a rapidly growing concern for youth. As rates of death by firearm rise, so does exposure to firearm violence and high levels of accompanying morbidity. Although gun violence cannot be attributed to any one cause, it is important pediatric health care providers understand the prevalence of this issue. Additionally, the long-term health effects are profound with many victims of, and witnesses to, gun violence experiencing new symptoms of general anxiety disorder. There are numerous initiatives taking place at the individual, local, and national levels to address this public health crisis. An overview of such interventions is also presented. With better screening and treatment of upstream and downstream symptoms of youth gun violence, pediatricians can decrease the morbidity and mortality that results from firearm use. <b>[<i>Pediatr Ann</i>. 2024;53(6):e197-e199.]</b>.</p>","PeriodicalId":54633,"journal":{"name":"Pediatric Annals","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141293973","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Safely Doing Less Antibiotics: Evidence to Guide Duration and Route of Administration in Common Pediatric Infections. 安全减少使用抗生素:指导常见儿科感染的用药时间和途径的证据》(Evidence to Guide Duration and Route of Administration in Common Pediatric Infections)。
IF 1.1 4区 医学 Q3 Medicine Pub Date : 2024-06-01 DOI: 10.3928/19382359-20240407-06
Alaina Shine, Polina Frolova Gregory, Shayna Herns, Abena Knight

The growing evidence detailing the harmful effects of exposure to antibiotics has driven an urgency to evaluate recommendations in common pediatric infections regarding antibiotic course duration and route of administration. The past decade has produced strong evidence in support of many patients with uncomplicated common pediatric infections receiving shortened antibiotic durations and early conversion from intravenous to oral antibiotics. In this review, we offer guidance to providers in selection of duration and route of administration in a subset of common pediatric infections, including community-acquired pneumonia, osteomyelitis, and infections of the head and neck. [Pediatr Ann. 2024;53(6):e229-e233.].

越来越多的证据详细说明了接触抗生素的有害影响,这促使人们迫切希望对常见儿科感染中有关抗生素疗程和给药途径的建议进行评估。过去十年中,有大量证据表明,许多无并发症的常见儿科感染患者接受抗生素治疗的疗程缩短,并尽早从静脉注射抗生素转为口服抗生素。在这篇综述中,我们将指导医疗服务提供者选择儿科常见感染的用药时间和途径,包括社区获得性肺炎、骨髓炎和头颈部感染。[2024; 53(6):e229-e233.].
{"title":"Safely Doing Less Antibiotics: Evidence to Guide Duration and Route of Administration in Common Pediatric Infections.","authors":"Alaina Shine, Polina Frolova Gregory, Shayna Herns, Abena Knight","doi":"10.3928/19382359-20240407-06","DOIUrl":"https://doi.org/10.3928/19382359-20240407-06","url":null,"abstract":"<p><p>The growing evidence detailing the harmful effects of exposure to antibiotics has driven an urgency to evaluate recommendations in common pediatric infections regarding antibiotic course duration and route of administration. The past decade has produced strong evidence in support of many patients with uncomplicated common pediatric infections receiving shortened antibiotic durations and early conversion from intravenous to oral antibiotics. In this review, we offer guidance to providers in selection of duration and route of administration in a subset of common pediatric infections, including community-acquired pneumonia, osteomyelitis, and infections of the head and neck. <b>[<i>Pediatr Ann</i>. 2024;53(6):e229-e233.]</b>.</p>","PeriodicalId":54633,"journal":{"name":"Pediatric Annals","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141293969","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tuberculosis in the United States: A Worrisome New Trend Amid Nearly 30 Years of Continued Decline. 美国的结核病:在近 30 年的持续下降中出现了令人担忧的新趋势。
IF 1.1 4区 医学 Q3 Medicine Pub Date : 2024-06-01 DOI: 10.3928/19382359-20240507-01
Lolita Alcocer Alkureishi, Joseph R Hageman
{"title":"Tuberculosis in the United States: A Worrisome New Trend Amid Nearly 30 Years of Continued Decline.","authors":"Lolita Alcocer Alkureishi, Joseph R Hageman","doi":"10.3928/19382359-20240507-01","DOIUrl":"https://doi.org/10.3928/19382359-20240507-01","url":null,"abstract":"","PeriodicalId":54633,"journal":{"name":"Pediatric Annals","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141293972","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of Neonatal Hyperbilirubinemia: Shedding Light on the American Academy of Pediatrics 2022 Clinical Practice Guideline Revision. 新生儿高胆红素血症的管理:解读美国儿科学会 2022 年临床实践指南修订版。
IF 1.1 4区 医学 Q3 PEDIATRICS Pub Date : 2024-06-01 DOI: 10.3928/19382359-20240407-02
Lindsey Daggle, Neha Sharma, Initha Setiady, Karen Leonard

Neonatal hyperbilirubinemia is one of the most common conditions managed by pediatricians. Although many infants are affected, most will experience complete resolution without complication. Acute bilirubin encephalopathy and kernicterus are rare yet debilitating sequelae of severe hyperbilirubinemia that can be avoided through careful monitoring and treatment with phototherapy. Appropriate management of neonatal hyperbilirubinemia must balance the risks of these severe conditions with the effects of overtreatment. Released in 2022, the American Academy of Pediatrics revised the clinical practice guideline for the management of hyperbilirubinemia, which aims to provide that balance through updates to the previous guideline. This article will provide the reader with (1) an evidence-based harm and benefit analysis of the guideline, (2) an overview of key changes and clarifications made in the new guideline, and (3) a practical summary of guideline updates. [Pediatr Ann. 2024;53(6):e208-e216.].

新生儿高胆红素血症是儿科医生最常处理的疾病之一。虽然很多婴儿都会受到影响,但大多数都会完全缓解,不会出现并发症。急性胆红素脑病和核黄疸是严重高胆红素血症的罕见后遗症,但可以通过仔细监测和光疗来避免。新生儿高胆红素血症的适当管理必须平衡这些严重病症的风险和过度治疗的影响。美国儿科学会于 2022 年修订了高胆红素血症管理的临床实践指南,旨在通过对之前指南的更新来实现这种平衡。本文将为读者提供:(1)基于证据的指南害处和益处分析;(2)新指南的主要变化和澄清概述;(3)指南更新的实用总结。[2024; 53(6):e208-e216.].
{"title":"Management of Neonatal Hyperbilirubinemia: Shedding Light on the American Academy of Pediatrics 2022 Clinical Practice Guideline Revision.","authors":"Lindsey Daggle, Neha Sharma, Initha Setiady, Karen Leonard","doi":"10.3928/19382359-20240407-02","DOIUrl":"10.3928/19382359-20240407-02","url":null,"abstract":"<p><p>Neonatal hyperbilirubinemia is one of the most common conditions managed by pediatricians. Although many infants are affected, most will experience complete resolution without complication. Acute bilirubin encephalopathy and kernicterus are rare yet debilitating sequelae of severe hyperbilirubinemia that can be avoided through careful monitoring and treatment with phototherapy. Appropriate management of neonatal hyperbilirubinemia must balance the risks of these severe conditions with the effects of overtreatment. Released in 2022, the American Academy of Pediatrics revised the clinical practice guideline for the management of hyperbilirubinemia, which aims to provide that balance through updates to the previous guideline. This article will provide the reader with (1) an evidence-based harm and benefit analysis of the guideline, (2) an overview of key changes and clarifications made in the new guideline, and (3) a practical summary of guideline updates. <b>[<i>Pediatr Ann</i>. 2024;53(6):e208-e216.]</b>.</p>","PeriodicalId":54633,"journal":{"name":"Pediatric Annals","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141293967","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bronchiolitis: Safely Doing Less Is the Next Big Thing. 支气管炎:安全少做是下一件大事。
IF 1.1 4区 医学 Q3 Medicine Pub Date : 2024-06-01 DOI: 10.3928/19382359-20240407-07
Amy Weis, Claire Hailey

Bronchiolitis is a viral lower respiratory tract infection primarily affecting children younger than 2 years; a common cause of health care encounters, including hospitalization; and a considerable economic burden for health care systems in the United States and worldwide. The American Academy of Pediatrics (AAP) most recently updated its bronchiolitis guideline in 2014 and reaffirmed supportive care as the mainstay of treatment. Despite these recommendations, there is still significant variability in care provided for these children, especially in bronchodilator usage, radiography, and high-flow nasal cannula. Since the 2014 AAP guideline, many pediatric hospitalists have undertaken quality initiatives to improve the adherence to published guidelines, yet a large gap remains between what is recommended and what is practiced. This article presents research on the efficacy of common interventions as well as an introduction to diagnostics and treatments potentially on the horizon. [Pediatr Ann. 2024;53(6):e223-e228.].

支气管炎是一种病毒性下呼吸道感染,主要影响 2 岁以下的儿童,是包括住院治疗在内的医疗就诊的常见原因,也给美国和全球的医疗系统造成了相当大的经济负担。美国儿科学会(AAP)最近于 2014 年更新了支气管炎指南,重申支持性护理是治疗的主要手段。尽管提出了这些建议,但为这些儿童提供的护理仍存在很大差异,尤其是在支气管扩张剂的使用、放射成像和高流量鼻插管方面。自 2014 年 AAP 指南发布以来,许多儿科住院医师已采取质量措施,以改善对已发布指南的遵守情况,但建议与实践之间仍存在很大差距。本文介绍了常见干预措施的疗效研究,并介绍了可能即将出现的诊断和治疗方法。[2024; 53(6):e223-e228.].
{"title":"Bronchiolitis: Safely Doing Less Is the Next Big Thing.","authors":"Amy Weis, Claire Hailey","doi":"10.3928/19382359-20240407-07","DOIUrl":"https://doi.org/10.3928/19382359-20240407-07","url":null,"abstract":"<p><p>Bronchiolitis is a viral lower respiratory tract infection primarily affecting children younger than 2 years; a common cause of health care encounters, including hospitalization; and a considerable economic burden for health care systems in the United States and worldwide. The American Academy of Pediatrics (AAP) most recently updated its bronchiolitis guideline in 2014 and reaffirmed supportive care as the mainstay of treatment. Despite these recommendations, there is still significant variability in care provided for these children, especially in bronchodilator usage, radiography, and high-flow nasal cannula. Since the 2014 AAP guideline, many pediatric hospitalists have undertaken quality initiatives to improve the adherence to published guidelines, yet a large gap remains between what is recommended and what is practiced. This article presents research on the efficacy of common interventions as well as an introduction to diagnostics and treatments potentially on the horizon. <b>[<i>Pediatr Ann</i>. 2024;53(6):e223-e228.]</b>.</p>","PeriodicalId":54633,"journal":{"name":"Pediatric Annals","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141293965","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Safely Doing Less in Pediatrics and Pediatric Hospital Medicine. 安全地减少儿科和儿科医院医疗的工作量。
IF 1.1 4区 医学 Q3 Medicine Pub Date : 2024-06-01 DOI: 10.3928/19382359-20240407-03
Stephanie Hom Deveau-Rosen, Natalie Guerrier McKnight
{"title":"Safely Doing Less in Pediatrics and Pediatric Hospital Medicine.","authors":"Stephanie Hom Deveau-Rosen, Natalie Guerrier McKnight","doi":"10.3928/19382359-20240407-03","DOIUrl":"https://doi.org/10.3928/19382359-20240407-03","url":null,"abstract":"","PeriodicalId":54633,"journal":{"name":"Pediatric Annals","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141293971","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Pediatric Annals
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1